机器学习能准确预测社区获得性肺炎住院患者对重症监护支持的需求
本研究为回顾性观察研究,纳入2420例COVID-19 CAP和1909例非COVID-19 CAP成人住院患者,且入院当天不需要有创通气、血管升压药或肾脏替代治疗。研究训练随机森林分类器(RFC)、支持向量机(SVM)、极端梯度提升(XGBoost)和多层感知机(MLP)模型,预测住院期间最终使用有创通气、血管升压药和肾脏替代治疗三个终点。RFC模型在推导COVID-19 CAP队列中总体最准确,并在一个COVID-19 CAP和两个非COVID-19 CAP队列中验证。机器学习预测三个终点的AUROC为0.74–0.95,逻辑回归为0.66–0.8。作者认为机器学习可辅助临床医生对住院CAP患者进行分诊和诊疗判断。
要点
- 在2420例COVID-19 CAP和1909例非COVID-19 CAP住院患者中,机器学习预测有创通气、血管升压药或肾脏替代治疗需求的AUROC为0.74–0.95。
- 随机森林分类器(RFC)模型总体优于XGBoost、SVM和MLP模型。
- 逻辑回归模型在同一队列中预测三个终点的AUROC为0.66–0.8,低于机器学习模型。
- 预测通气或血管升压药使用使用了FiO2、格拉斯哥昏迷评分和平均动脉压等变量,预测肾脏替代治疗使用使用了肌酐和钾等变量。
- 作者认为机器学习算法比回归模型更准确地预测住院COVID-19和非COVID-19 CAP患者对有创通气、血管升压药或肾脏替代治疗的需求,可辅助临床医生分诊和诊疗判断。
适用人群与场景
- 年龄大于18岁、因社区获得性肺炎住院、且入院当天不需要有创通气、血管升压药和肾脏替代治疗的患者。
- 包括2420例COVID-19 CAP患者和1909例非COVID-19 CAP患者。
研究设计与关键结果
- 研究类型为回顾性观察研究,纳入2420例COVID-19 CAP和1909例非COVID-19 CAP成人住院患者。
- 研究训练随机森林分类器(RFC)、支持向量机(SVM)、极端梯度提升(XGBoost)和多层感知机(MLP)模型,预测住院期间最终使用有创通气、血管升压药和肾脏替代治疗三个终点。
- RFC模型在推导COVID-19 CAP队列中总体最准确,并在一个COVID-19 CAP队列和两个非COVID-19 CAP队列中验证。
- 机器学习模型预测有创通气、血管升压药和肾脏替代治疗使用的AUROC为0.74–0.95。
- 逻辑回归模型在同一队列中预测三个终点的AUROC为0.66–0.8,低于机器学习模型。
- 预测通气或血管升压药使用使用了FiO2、格拉斯哥昏迷评分和平均动脉压等变量,预测肾脏替代治疗使用使用了肌酐和钾等变量。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为机器学习算法比回归模型更准确地预测住院COVID-19和非COVID-19 CAP患者对有创通气、血管升压药或肾脏替代治疗的需求,可辅助临床医生分诊和诊疗判断。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Hospitalized community-acquired pneumonia (CAP) patients are admitted for ventilation, vasopressors, and renal replacement therapy (RRT). This study aimed to develop a machine learning (ML) model that predicts the need for such interventions and compare its accuracy to that of logistic regression (LR).
DESIGN: This retrospective observational study trained separate models using random-forest classifier (RFC), support vector machines (SVMs), Extreme Gradient Boosting (XGBoost), and multilayer perceptron (MLP) to predict three endpoints: eventual use of invasive ventilation, vasopressors, and RRT during hospitalization. RFC-based models were overall most accurate in a derivation COVID-19 CAP cohort and were validated in one COVID-19 CAP and two non-COVID-19 CAP cohorts.
SETTING: This study is part of the Community-Acquired Pneumonia: Toward InnoVAtive Treatment (CAPTIVATE) Research program.
PATIENTS: Two thousand four hundred twenty COVID-19 and 1909 non-COVID-19 CAP patients over 18 years old hospitalized and not needing invasive ventilation, vasopressors, and RRT on the day of admission were included.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Performance was evaluated with area under the receiver operating characteristic curve (AUROC) and accuracy. RFCs performed better than XGBoost, SVM, and MLP models. For comparison, we evaluated LR models in the same cohorts. AUROC was very high ranging from 0.74 to 0.95 in predicting ventilation, vasopressors, and RRT use in our derivation and validation cohorts. ML used and variables such as Fio2, Glasgow Coma Scale, and mean arterial pressure to predict ventilator, vasopressor use, creatinine, and potassium to predict RRT use. LR was less accurate than ML, with AUROC ranging 0.66 to 0.8.
CONCLUSIONS: A ML algorithm more accurately predicts need of invasive ventilation, vasopressors, or RRT in hospitalized non-COVID-19 CAP and COVID-19 patients than regression models and could augment clinician judgment for triage and care of hospitalized CAP patients.
参考来源
- Chen GS, Lee T, Tsang JLY, et al. Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired Pneumonia. Crit Care Explor. 2025. PMID: 40443788. doi:10.1097/CCE.0000000000001262
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。